DEXA scans, bioelectrical impedance analysis, and hydrostatic weighing can all measure body fat percentage accurately
Systolic blood pressure reduction with Tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program
Eligibility Criteria Your PCP Will Evaluate PCPs screen for GLP-1 appropriateness using standardized criteria: BMI 30, or BMI 27 with weight-related comorbidities (diabetes, hypertension, sleep apnea)
GLP-1 patches are an emerging technology being studied as an alternative to injectable GLP-1 receptor agonists, which are medications commonly prescribed for type 2 diabetes and weight management
The complete guide on GLP-1 and breastfeeding reviews the available evidence, but the decision to use any GLP-1 medication while nursing should involve a thorough risk-benefit discussion with your doctor
While research in humans is still in the early stages, these findings point to the possibility that GLP-1-based treatments could help reduce cravings and withdrawal symptoms in individuals attempting to quit smoking
